Survival and Clinical Outcomes with Telotristat Ethyl in Patients with Carcinoid Syndrome

David C Metz,1 Eric Liu,2 Vijay N Joish,3 Lynn Huynh,4 Todor I Totev,4 Mei Sheng Duh,4 Kiernan Seth,3 Susan Giacalone,3 Pablo Lapuerta,3 Michael A Morse5 1Neuroendocrine Tumor Program at Penn Medicine, Philadelphia, PA 19104, USA; 2The Neuroendocrine Institute at Rocky Mountain Cancer Centers, Denve...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Metz DC, Liu E, Joish VN, Huynh L, Totev TI, Duh MS, Seth K, Giacalone S, Lapuerta P, Morse MA
Formato: Artigo
Idioma:Inglês
Publicado em: Dove Medical Press 2020-10-01
Colecção:Cancer Management and Research
Assuntos:
neuroendocrine tumors
carcinoid syndrome
telotristat ethyl
survival
Acesso em linha:https://www.dovepress.com/survival-and-clinical-outcomes-with-telotristat-ethyl-in-patients-with-peer-reviewed-article-CMAR
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados